XPH

SPDR S&P Pharmaceuticals ETF

Up$38.94
+$0.05
(+0.13%)
As of 6:40:00 PM EDT | 4/22/19  |  Market Closed

XPH Trading Data

Open

$38.76

Low Price

$38.47

High Price

$39.03

Previous Last Price

$38.89

Bid Size

$38.24 X 2000

Ask Size

$39.66 X 2000

XPH Portfolio Data

AUM

$225,569,800

Shares

5,800

PE Ratio

9.53

Price / Book Ratio

2.45

Expense Ratio

0.35

Net Asset Value

$38.89

Volume

Volume

96,300

Avg. Volume (YDT)

63,242

Dollar Volume

$0

Weekly Avg. Volume

68,820

Monthly Avg. Volume

59,480

Quarterly Avg. Volume

57,682

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Zoetis Inc. Class A (ZTS)
5.06%
Elanco Animal Health Inc. (ELAN)
5%
Perrigo Co. Plc (PRGO)
4.96%
Mylan N.V. (MYL)
4.77%
Johnson & Johnson (JNJ)
4.7%
Jazz Pharmaceuticals Plc (JAZZ)
4.58%
Allergan plc (AGN)
4.57%
Pfizer Inc. (PFE)
4.55%
Merck & Co. Inc. (MRK)
4.33%
Eli Lilly and Company (LLY)
4.3%

Total XPH Holdings

Total Holdings: 44

Zoetis Inc. Class A (ZTS)
5.06%
Elanco Animal Health Inc. (ELAN)
5%
Perrigo Co. Plc (PRGO)
4.96%
Mylan N.V. (MYL)
4.77%
Johnson & Johnson (JNJ)
4.7%
Jazz Pharmaceuticals Plc (JAZZ)
4.58%
Allergan plc (AGN)
4.57%
Pfizer Inc. (PFE)
4.55%
Merck & Co. Inc. (MRK)
4.33%
Eli Lilly and Company (LLY)
4.3%
Nektar Therapeutics (NKTR)
4.26%
Catalent Inc (CTLT)
4.19%
Bristol-Myers Squibb Company (BMY)
4.18%
Mallinckrodt Plc (MNK)
3.44%
Horizon Pharma plc (HZNP)
3.33%
Medicines Company (MDCO)
3.16%
Endo International Plc (ENDP)
2.5%
Pacira Biosciences Inc. (PCRX)
2.38%
Aerie Pharmaceuticals Inc. (AERI)
2.33%
Supernus Pharmaceuticals Inc. (SUPN)
2.24%
Corcept Therapeutics Incorporated. (CORT)
2.07%
Innoviva Inc. (INVA)
1.89%
Prestige Consumer Healthcare Inc (PBH)
1.8%
MyoKardia Inc. (MYOK)
1.71%
Zogenix Inc. (ZGNX)
1.5%
Reata Pharmaceuticals Inc. Class A (RETA)
1.35%
TherapeuticsMD Inc. (TXMD)
1.33%
Amneal Pharmaceuticals Inc. Class A (AMRX)
1.22%
Omeros Corporation (OMER)
1.15%
Intersect ENT Inc (XENT)
0.87%
Akorn Inc. (AKRX)
0.87%
Revance Therapeutics Inc. (RVNC)
0.64%
CymaBay Therapeutics Inc. (CBAY)
0.58%
Wave Life Sciences Ltd. (WVE)
0.57%
Tricida Inc (TCDA)
0.56%
Collegium Pharmaceutical Inc. (COLL)
0.54%
Intra-Cellular Therapies Inc. (ITCI)
0.54%
Phibro Animal Health Corporation Class A (PAHC)
0.52%
Theravance Biopharma Inc (TBPH)
0.52%
ANI Pharmaceuticals Inc. (ANIP)
0.5%
Amphastar Pharmaceuticals Inc (AMPH)
0.4%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.12%
SPDR S & P Pharmaceuticals ETF (XPH)
0%
U.S. Dollar
0%

XPH Technicals

Alpha

-11.36

Beta

1.42

Leverage

Long

Standard Deviation

3.25

XPH Dividends

Dividend Date

2019-03-18

Latest Dividend

0.068

Annual Dividend

0.29

Annual Dividend Rate

0.29

Annual Dividend Yield

0.74

XPH Performance

YTD Return

6.34%

1 Year Return

-6.57%

3 Year Return

-7.9%

5 Year Return

-18.82%

10 Year Return

197.48%

XPH Related Articles